Garrey Carruthers Sells 1,300 Shares of Molina Healthcare Inc (MOH) Stock

Molina Healthcare Inc (NYSE:MOH) Director Garrey Carruthers sold 1,300 shares of the firm’s stock in a transaction that occurred on Thursday, November 16th. The stock was sold at an average price of $75.66, for a total value of $98,358.00. Following the sale, the director now directly owns 7,016 shares of the company’s stock, valued at approximately $530,830.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Molina Healthcare Inc (MOH) traded down $0.91 during mid-day trading on Friday, hitting $74.79. The stock had a trading volume of 1,195,550 shares, compared to its average volume of 1,267,959. Molina Healthcare Inc has a 52 week low of $42.56 and a 52 week high of $80.65. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 1.06. The company has a market capitalization of $4,340.00, a price-to-earnings ratio of 24.24 and a beta of 0.91.

Molina Healthcare (NYSE:MOH) last posted its earnings results on Thursday, November 2nd. The company reported ($1.62) earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.23 by ($1.85). Molina Healthcare had a negative net margin of 1.76% and a positive return on equity of 17.76%. The company had revenue of $5.03 billion during the quarter, compared to the consensus estimate of $4.95 billion. During the same quarter in the prior year, the business earned $0.85 EPS. The firm’s revenue for the quarter was up 10.7% compared to the same quarter last year. research analysts expect that Molina Healthcare Inc will post -3.88 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “Garrey Carruthers Sells 1,300 Shares of Molina Healthcare Inc (MOH) Stock” was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright law. The correct version of this piece of content can be read at https://www.dispatchtribunal.com/2017/11/18/garrey-carruthers-sells-1300-shares-of-molina-healthcare-inc-moh-stock.html.

Hedge funds have recently bought and sold shares of the company. Zions Bancorporation bought a new position in shares of Molina Healthcare in the third quarter valued at approximately $118,000. LS Investment Advisors LLC lifted its holdings in shares of Molina Healthcare by 40.9% in the second quarter. LS Investment Advisors LLC now owns 1,829 shares of the company’s stock valued at $127,000 after purchasing an additional 531 shares in the last quarter. Meeder Asset Management Inc. bought a new position in shares of Molina Healthcare in the second quarter valued at approximately $136,000. Riverhead Capital Management LLC lifted its holdings in shares of Molina Healthcare by 64.2% in the second quarter. Riverhead Capital Management LLC now owns 2,463 shares of the company’s stock valued at $170,000 after purchasing an additional 963 shares in the last quarter. Finally, Sabal Trust CO bought a new position in shares of Molina Healthcare in the third quarter valued at approximately $206,000. Institutional investors own 95.04% of the company’s stock.

Several research firms recently commented on MOH. ValuEngine raised Molina Healthcare from a “hold” rating to a “buy” rating in a research note on Thursday, November 9th. Zacks Investment Research raised Molina Healthcare from a “sell” rating to a “hold” rating in a research note on Monday, November 6th. Morgan Stanley raised their target price on Molina Healthcare from $68.00 to $89.00 and gave the stock an “overweight” rating in a research note on Friday, November 3rd. Jefferies Group LLC raised their target price on Molina Healthcare from $64.00 to $74.00 and gave the stock a “hold” rating in a research note on Friday, November 3rd. Finally, Wolfe Research raised Molina Healthcare from a “market perform” rating to an “outperform” rating in a research note on Monday, October 23rd. Three analysts have rated the stock with a sell rating, nine have assigned a hold rating and six have assigned a buy rating to the stock. Molina Healthcare currently has an average rating of “Hold” and an average target price of $64.30.

About Molina Healthcare

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Insider Buying and Selling by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply